←Back to list

Project Orca

Stealth-mode technology venture; board includes Austin McChord (Datto founder) and Paul Sagan
Project Orca is a private other company that filed a SEC Form D on 2026-05-07 disclosing a $70.0M Regulation D offering. Officers and directors of record include Michael Fass, Austin McChord, Rexhi Dollaku, Paul Sagan. Additional company details to be enriched from press and IR sources.
Other
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is Project Orca going public?
No. Project Orca is private and has not filed to go public. There is no S-1 on file.
What is Project Orca's valuation in 2026?
No confirmed valuation is on record for Project Orca. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Project Orca filed an S-1?
No public S-1 is on file for Project Orca.
Who are Project Orca's investors?
Project Orca's investors include Rexhi Dollaku, Paul Sagan.
How much has Project Orca raised?
Project Orca has raised $70M in total, most recently a Form D filing of $70M in May 2026.
Is Project Orca publicly traded — can you buy Project Orca stock?
No. Project Orca is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Project Orca on its Pre-IPO Access Desk.
How to actually get exposure to Project Orca →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Michael Fass
Total Raised
$70M
Growth
Filed SEC Form D on 2026-05-07 for $70.0M Regulation D offering
Last Round
Form D filing — $70M (May 2026)
IPO Status
private

Fundraising Status

Form D filing · $70M · 5 mo ago
privateTotal raised $70M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Form D filing$70MMay 2026——

Talent Signal

Hiring trend
▶ Hiring steady
28% of roles posted in last 30d
Open roles
50
via lever
Product-build share
38%
engineering, research, product, design
Trajectory
strengthening
balanced build + GTM — 38% builders vs 62% go-to-market/G&A — scaling both sides.
Recent senior hire: 1 senior hire (CPO).
Open roles by month
Open roles by month50Sep '26
Open roles by function
Open roles by functionOther17Hardware9Ops & People8Clinical & Science6Research2Engineering2Sales & GTM2Marketing1Legal & Policy1
■ product-building   ■ go-to-market / G&A
Key Executive Moves
INGera DorfmanCPO · 2026-08-17
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Clinical Research AssociateDirector/Head, PharmacovigilanceEngineer, Manufacturing Sciences & Technology (MSAT) (3rd Shift)Engineer, Packaging and LabelingGeneral Manager, Commercial Manufacturing FacilityManufacturing Process Lead (3rd Shift)
Counted from Project Orca's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Investors

Rexhi Dollaku · Paul Sagan
OtherNew
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.